Bufalin Suppresses Migration and Invasion of Hepatocellular Carcinoma Cells Elicited by Poly (I:C) Therapy

The Toll-like receptor 3 (TLR3) agonists as polyriboinosinic–polyribocytidylic acid (poly (I:C)) have been implicated as potential immunotherapy adjuvant for cancer whereas the exact roles of TLR3 agonists in hepatocellular carcinoma (HCC) treatment have not been clearly evaluated. In consistent wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Yinglu, Chen, Yongan, Meng, Yongbin, Cao, Qingxin, Liu, Qun, Ling, Changquan, Wang, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927531/
https://www.ncbi.nlm.nih.gov/pubmed/29721392
http://dx.doi.org/10.1080/2162402X.2018.1426434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5927531/
https://www.ncbi.nlm.nih.gov/pubmed/29721392
http://dx.doi.org/10.1080/2162402X.2018.1426434

Ejemplares similares